CoChat

Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use

Open access

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Purpose: To gain comprehensive information on the burden of illness due to geographic atrophy (GA). Methods: This cross-sectional study with a retrospective chart review involved patients aged ≥70 years with physician-confirmed bilateral symptomatic GA due to age-related macular degeneration (GA group), as well as patients of similar age with no ophthalmic condition that in the opinion of the investigator affected visual function (non-GA group). Data relating to patients’ current disease status and sociodemographics were self-reported on patient questionnaires at study entry and extracted from patient charts. Historical data on health care resource utilization (HCRU) were also collected via patient questionnaires and retrospective chart review (GA group only). Overall vision-related functioning and quality of life (QoL) were compared between the GA and non-GA groups using the National Eye Institute Visual Function Questionnaire-25 (NEI-VFQ-25) composite and subscales, and change in vision over the past year was assessed using the Global Rating of Change Scale. Results: Vision-related functioning and QoL were poorer in patients with vs without GA (n=137 vs 52), as demonstrated by significantly lower NEI-VFQ-25 composite score (mean, 53.1 vs 84.5 points, respectively; P <0.001), as well as lower subscale scores for near activities, distance activities, dependency, driving, social functioning, mental health, role difficulties, color vision, and peripheral vision. Substantially more patients with GA than without GA reported worsening in vision over the past year (82% vs 25%, respectively; odds ratio, 13.55; P <0.001). In the GA group, associated mean annual costs for direct ophthalmological resource use per patient amounted to €1772 (mostly for tests/procedures), and for indirect ophthalmological resource use, €410 (mostly for general practitioner visits). Conclusion: Patients with GA experience a poorer level of vision-related function and QoL than their peers, especially in relation to driving. GA is also associated with notable HCRU/associated costs, mostly direct costs attributed to diagnostic tests/procedures. Keywords: burden of illness, geographic atrophy, vision-related quality of life, health care resource utilization, visual function, health care costs

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/opth.s226425

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Flow diagram showing the study population enrolled in a cross-sectional study across 17 sites in the United Kingdom, Germany, Ireland, and Canada. Notes: aReasons for exclusion from analysis, GA group: non-bilateral physician-confirmed GA; age ≤70 years at study inclusion; no informed consent; history of CNV, DME, and/or RVO; protocol deviation. bReasons for exclusion from analysis, non-GA group: ophthalmic condition affecting visual function; no informed consent; history of CNV, DME, and/or RVO. cA site in Ireland leveraged electronic medical records to actively recall patients slightly earlier than their scheduled visit during the initial recruitment phase. Inclusion of these patients would have affected health care resource utilization results, so the protocol had to be clarified mid study, and a decision was made to exclude these patients from the analysis due to protocol deviation following this protocol change. Subsequent patients that were contributed by this site were recruited according to updated protocols (recruitment only during routine visits). Abbreviations: CNV, choroidal neovascularization; DME, diabetic macular edema; GA, geographic atrophy; RVO, retinal vein occlusion.
Figure 1 Flow diagram showing the study population enrolled in a cross-sectional study across 17 sites in the United Kingdom, Germany, Ireland, and Canada. Notes: aReasons for exclusion from analysis, GA group: non-bilateral physician-confirmed GA; age ≤70 years at study inclusion; no informed consent; history of CNV, DME, and/or RVO; protocol deviation. bReasons for exclusion from analysis, non-GA group: ophthalmic condition affecting visual function; no informed consent; history of CNV, DME, and/or RVO. cA site in Ireland leveraged electronic medical records to actively recall patients slightly earlier than their scheduled visit during the initial recruitment phase. Inclusion of these patients would have affected health care resource utilization results, so the protocol had to be clarified mid study, and a decision was made to exclude these patients from the analysis due to protocol deviation following this protocol change. Subsequent patients that were contributed by this site were recruited according to updated protocols (recruitment only during routine visits). Abbreviations: CNV, choroidal neovascularization; DME, diabetic macular edema; GA, geographic atrophy; RVO, retinal vein occlusion.CC BY-NC · PubMed Central
Figure 2 Mean (95% CI) NEI-VFQ-25 scores for the GA and non-GA groups in a cross-sectional study conducted in 17 sites in the United Kingdom, Germany, Ireland, and Canada.a Notes: aComposite and subscale scores range from 0–100, with higher scores indicating better vision-related functioning. Additional subscales are provided in Table S5. *P<0.001 by Wilcoxon rank-sum test. Abbreviations: GA, geographic atrophy; NEI-VFQ-25, National Eye Institute Visual Function Questionnaire-25.
Figure 2 Mean (95% CI) NEI-VFQ-25 scores for the GA and non-GA groups in a cross-sectional study conducted in 17 sites in the United Kingdom, Germany, Ireland, and Canada.a Notes: aComposite and subscale scores range from 0–100, with higher scores indicating better vision-related functioning. Additional subscales are provided in Table S5. *P<0.001 by Wilcoxon rank-sum test. Abbreviations: GA, geographic atrophy; NEI-VFQ-25, National Eye Institute Visual Function Questionnaire-25.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 1

  1. [14]Orr S. Disease burden associated with geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci. 2016; 57(12): 21.

Cited by

See all 61

Metadata

Authors
Patel, P. J., Ziemssen, F., Ng, E., Muthutantri, A., Silverman, D., Tschosik, E. A., & Cantrell, R. A.
Affiliations
  • Moorfields Eye Hospital NHS Foundation Trust (GB)
  • University of Tübingen (DE)
  • Waterford Institute of Technology (IE)
  • IQVIA (United Kingdom) (GB)
  • Roche (United Kingdom) (GB)
  • Roche (United States) (US)
Corresponding author
Silverman, David
Venue
Clinical Ophthalmology
Published
2020-01
Volume
Volume 14
Pages
15-28
ISSN
  • 1177-5467 (ISSN-L)
  • 1177-5483
OpenAlex
W2999121317
Cited by
61
References
38
Citations by year
2026: 11 · 2025: 16 · 2024: 16 · 2023: 9 · 2022: 4 · 2021: 5
FWCI
3.55
Type
journal article
Language
en
Open access
Locations
  • Clinical ophthalmology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Funders
  • F. Hoffmann-La Roche
  • Nottingham University Hospitals NHS Trust
  • University of Nottingham
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Ophthalmology and Visual Impairment Studies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
geographic atrophy, age-related macular degeneration, disease burden, vision-related quality of life, healthcare resource utilization, health care costs, visual function, driving impairment, NEI VFQ-25, older adults

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use. https://app.cochat.ai/papers/10.2147/opth.s226425
The paper
Patel, P. J., Ziemssen, F., Ng, E., Muthutantri, A., Silverman, D., Tschosik, E. A., & Cantrell, R. A. (2020). Burden of Illness in Geographic Atrophy: A Study of Vision-Related Quality of Life and Health Care Resource Use. Clinical Ophthalmology. https://doi.org/10.2147/opth.s226425

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.